Ann Arbor, MI - March 14, 2006 - Compendia Bioscience, Inc., a newly formed bioinformatics company, has received exclusive rights from the University of Michigan for the development and support of Oncomine, an industry leading cancer profiling database. “Compendia Bioscience is delighted to develop and commercialize Oncomine for the biotechnology and pharmaceutical industries. Building on a base of 7,000 existing users we anticipate accelerated design and functionality enhancements tailored to the specific needs of the commercial sector.” said Arul M. Chinnaiyan, M.D., Ph.D., S.P. Hicks Professor of Pathology and co-founder of Compendia Bioscience, Inc.
